Stocks
Dermata Therapeutics, Inc.DRMA
NASDAQHealthcareBiotechnology$0.86
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing topical therapies for dermatological conditions, with its lead candidate targeting inflammatory skin diseases. Investors track the stock for its pipeline progress and regulatory milestones, though the company has yet to generate product revenue.
52W Range: $0.60-$4.66
Congressional Interest in Dermata Therapeutics, Inc. (DRMA)
No congressional trades have been disclosed for Dermata Therapeutics, Inc. (DRMA) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading DRMA?
No congressional trades found for this stock.